Hirano T - Search Results

1

Antitumor activity of tumor necrosis factor alpha conjugated with divinyl ether and maleic anhydride copolymer on solid tumors in mice.

Kaneda Y, Yamamoto Y, Kamada H, Tsunoda S, Tsutsumi Y, Hirano T, Mayumi T. Kaneda Y, et al. Among authors: hirano t. Cancer Res. 1998 Jan 15;58(2):290-5. Cancer Res. 1998. PMID: 9443407

2

Enhanced antitumor potency of polyethylene glycolylated tumor necrosis factor-alpha: a novel polymer-conjugation technique with a reversible amino-protective reagent.

Tsunoda S, Ishikawa T, Yamamoto Y, Kamada H, Koizumi K, Matsui J, Tsutsumi Y, Hirano T, Mayumi T. Tsunoda S, et al. Among authors: hirano t. J Pharmacol Exp Ther. 1999 Jul;290(1):368-72. J Pharmacol Exp Ther. 1999. PMID: 10381801

3

Molecular design of polyvinylpyrrolidone-conjugated interleukin-6 for enhancement of in vivo thrombopoietic activity in mice.

Tsunoda S, Kamada H, Yamamoto Y, Ishikawa T, Matsui J, Koizumi K, Kaneda Y, Tsutsumi Y, Ohsugi Y, Hirano T, Mayumi T. Tsunoda S, et al. Among authors: hirano t. J Control Release. 2000 Sep 3;68(3):335-41. doi: 10.1016/s0168-3659(00)00249-2. J Control Release. 2000. PMID: 10974387

4

Bioconjugation of tumor necrosis factor-alpha with the copolymer of divinyl ether and maleic anhydride increasing its antitumor potency.

Kaneda Y, Yamamoto Y, Tsunoda S, Kamada H, Tsutsumi Y, Hirano T, Mayumi T. Kaneda Y, et al. Among authors: hirano t. Biochem Biophys Res Commun. 1997 Oct 9;239(1):160-5. doi: 10.1006/bbrc.1997.7330. Biochem Biophys Res Commun. 1997. PMID: 9345288

5

Reduced bone marrow toxicity of neocarzinostatin by conjugation with divinyl ether-maleic acid copolymer.

Yamamoto H, Miki T, Oda T, Hirano T, Sera Y, Akagi M, Maeda H. Yamamoto H, et al. Among authors: hirano t. Eur J Cancer. 1990 Mar;26(3):253-60. doi: 10.1016/0277-5379(90)90219-j. Eur J Cancer. 1990. PMID: 2141482

6

Safety evaluation of hemagglutinating virus of Japan--artificial viral envelope liposomes in nonhuman primates.

Tsuboniwa N, Morishita R, Hirano T, Fujimoto J, Furukawa S, Kikumori M, Okuyama A, Kaneda Y. Tsuboniwa N, et al. Among authors: hirano t. Hum Gene Ther. 2001 Mar 20;12(5):469-87. doi: 10.1089/104303401300042366. Hum Gene Ther. 2001. PMID: 11268281

7

HVJ-liposome-mediated transfection of HSVtk gene driven by AFP promoter inhibits hepatic tumor growth of hepatocellular carcinoma in SCID mice.

Hirano T, Kaneko S, Kaneda Y, Saito I, Tamaoki T, Furuyama J, Tamaoki T, Kobayashi K, Ueki T, Fujimoto J. Hirano T, et al. Gene Ther. 2001 Jan;8(1):80-3. doi: 10.1038/sj.gt.3301355. Gene Ther. 2001. PMID: 11402306

8

Combinations of olmesartan and a calcium channel blocker or a diuretic in elderly hypertensive patients: a randomized, controlled trial.

Ogihara T, Saruta T, Rakugi H, Saito I, Shimamoto K, Matsuoka H, Shimada K, Ito S, Horiuchi M, Imaizumi T, Takishita S, Higaki J, Katayama S, Kimura G, Umemura S, Ura N, Hayashi K, Odawara M, Tanahashi N, Ishimitsu T, Kashihara N, Morita S, Teramukai S; COLM Investigators. Ogihara T, et al. J Hypertens. 2014 Oct;32(10):2054-63; discussiom 2063. doi: 10.1097/HJH.0000000000000281. J Hypertens. 2014. PMID: 24999799 Free PMC article. Clinical Trial.

9

Tc-99m pertechnetate accumulation in osteotomy site.

Hirano T, Ichikawa K, Yokoyama M, Yamamoto Y, Naruko H. Hirano T, et al. Clin Nucl Med. 1995 Nov;20(11):1025-6. doi: 10.1097/00003072-199511000-00025. Clin Nucl Med. 1995. PMID: 8565363 No abstract available.

10

The in vivo anti-tumor effect of human recombinant interleukin-6.

Kitahara M, Kishimoto S, Hirano T, Kishimoto T, Okada M. Kitahara M, et al. Among authors: hirano t. Jpn J Cancer Res. 1990 Oct;81(10):1032-8. doi: 10.1111/j.1349-7006.1990.tb03342.x. Jpn J Cancer Res. 1990. PMID: 2121676 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

4,208 results

Search Page